BioSpace News Archive

Biotech Beach

Ka-Ching! BioAtla Raises $72.5 Million Series D Round

Prior to this raise, according to Crunchbase, the company had raised $114 million.

July 15, 2020
·
3 min read
·
Mark Terry
Business

BioSpace 2020 Salary Report Highlights Growing Gender Pay Gap and Other Vital Data

Today BioSpace released its second annual 2020 U.S. Life Sciences Salary Report, revealing surprising – and sometimes shocking – results. Here’s a look at some of the topline data.

July 15, 2020
·
3 min read
·
Gail Dutton
Business

Merck CEO Expresses Concern About Rapid COVID-19 Vaccine Development

Ken Frazier, Merck’s chief executive officer, is reminding the world that vaccine development takes time, typically a decade, and hoping for a viable vaccine against the novel coronavirus by the end of December is premature.

July 15, 2020
·
2 min read
·
Alex Keown
Drug Development

Moderna’s COVID-19 Vaccine Shows Early Promise in Phase I Trial

The interim analysis was of a two-dose vaccination schedule given 28 days apart at three different dose levels, 25, 100 and 250 micrograms in 45 healthy adults ranging in age from 18 to 55 years.

July 15, 2020
·
5 min read
·
Mark Terry
Policy

FDA Advisory Committee Votes 12-0 to Recommend GSK’s Multiple Myeloma Drug Belantamab Mafodotin

“We are pleased the committee recognized the potential for belantamab mafodotin to help patients who have relapsed or refractory multiple myeloma, an incurable disease with limited treatment options,” said Axel Hoos, senior vice president and heat of Oncology R&D for GSK.

July 15, 2020
·
3 min read
·
Mark Terry
Business

IDbyDNA Brings Metagenomics to the COVID-19 Fight

Metagenomics can look across the entire genomic sequence of more than 50,000 species of organisms that may be present in a patient sample and compare millions of sequences from a patient with millions of reference sequences.

July 15, 2020
·
5 min read
·
Gail Dutton
Genetown

Glympse Bio Secures $46.7 Million to Advance NASH Biosensor Program

Glympse Bio secured $46.7 million in a Series B fundraising round that will be used to support continued development of the company’s novel biosensor platform in fibrotic diseases such as Non-Alcoholic Steatohepatitis (NASH), oncology, and infectious diseases.

July 15, 2020
·
3 min read
·
Alex Keown
Drug Development

UK Institute Develops Llama-Derived Nanobodies as Possible COVID-19 Therapy

Nanobodies derived from llamas have neutralized the SARS-CoV-2 spike in the lab, effectively neutralizing the virus, according to research from the UK’s Rosalind Franklin Institute.

July 15, 2020
·
4 min read
·
Gail Dutton
BioSpace Global Roundup, July 16

Biopharma and life sciences companies from across the globe provide updates on their business and pipelines.

July 15, 2020
·
5 min read
·
Alex Keown
Business

NovoCure, Merck Team Up on Phase II Lung Cancer Trial

Together, the companies will develop Tumor Treating Fields with Merck’s anti-PD-1 therapy, Keytruda for the treatment of non-small cell lung cancer (NSCLC).

July 15, 2020
·
3 min read
·
Krystle Vermes